SynDiag

SynDiag is an Italian fem-tech company developing artificial intelligence-enabled medical devices for gynecological diagnostics, with a particular focus on the early detection of ovarian cancer and other gynecological lesions. Its technology is designed to support clinicians with objective, data-informed insights while keeping medical professionals in control of clinical decisions.

The company offers OvAI Focus, a tool that quantifies and describes pelvic organ anatomy to support efficient examinations and more standardized reporting, and OvAI X, an advanced decision-support product for assessing ovarian lesions and their risk class. SynDiag also works with healthcare organizations to integrate AI into clinical workflows and provides women with prevention information and access to partner clinical centers using its technology.

Alongside its products, SynDiag offers clinical resources, evidence-based materials, specialist courses, webinars, live events, and educational content through its Academy and blog. The company emphasizes scientifically grounded development, explainable human-in-the-loop AI, data privacy, and responsible adoption. Its work draws on nine years of research and development, more than 2,000 clinical cases, six patents, and collaboration with 12 clinical centers in Italy and abroad.